These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 17687191)
1. Mechanistic analysis of VDR-mediated renin suppression. Nakane M; Ma J; Ruan X; Kroeger PE; Wu-Wong R Nephron Physiol; 2007; 107(2):p35-44. PubMed ID: 17687191 [TBL] [Abstract][Full Text] [Related]
2. Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells. Wu-Wong JR; Nakane M; Ma J; Ruan X; Kroeger PE Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1592-604. PubMed ID: 17715259 [TBL] [Abstract][Full Text] [Related]
3. VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells. Wu-Wong JR; Nakane M; Ma J; Ruan X; Kroeger PE J Cell Biochem; 2007 Apr; 100(6):1395-405. PubMed ID: 17115413 [TBL] [Abstract][Full Text] [Related]
4. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Zella LA; Kim S; Shevde NK; Pike JW Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728 [TBL] [Abstract][Full Text] [Related]
5. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs. Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639 [TBL] [Abstract][Full Text] [Related]
6. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. Kim S; Shevde NK; Pike JW J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825 [TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 mice. Fryer RM; Rakestraw PA; Nakane M; Dixon D; Banfor PN; Koch KA; Wu-Wong JR; Reinhart GA Nephron Physiol; 2007; 106(4):p76-81. PubMed ID: 17622742 [TBL] [Abstract][Full Text] [Related]
8. Histamine receptor H1 and dermatopontin: new downstream targets of the vitamin D receptor. Pochampally RR; Ylostalo J; Penfornis P; Matz RR; Smith JR; Prockop DJ J Bone Miner Res; 2007 Sep; 22(9):1338-49. PubMed ID: 17547532 [TBL] [Abstract][Full Text] [Related]
9. An essential role of the CAAT/enhancer binding protein-alpha in the vitamin D-induced expression of the human steroid/bile acid-sulfotransferase (SULT2A1). Song CS; Echchgadda I; Seo YK; Oh T; Kim S; Kim SA; Cho S; Shi L; Chatterjee B Mol Endocrinol; 2006 Apr; 20(4):795-808. PubMed ID: 16357103 [TBL] [Abstract][Full Text] [Related]
10. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3). Chen ML; Ray S; Swamy N; Holick MF; Ray R Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974 [TBL] [Abstract][Full Text] [Related]
11. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor. Harant H; Spinner D; Reddy GS; Lindley IJ J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570 [TBL] [Abstract][Full Text] [Related]
12. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138 [TBL] [Abstract][Full Text] [Related]
13. Increased expression of corepressors in aggressive androgen-independent prostate cancer cells results in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness. Ting HJ; Bao BY; Reeder JE; Messing EM; Lee YF Mol Cancer Res; 2007 Sep; 5(9):967-80. PubMed ID: 17855664 [TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells. Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428 [TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol. Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583 [TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor activators upregulate and rescue podocalyxin expression in high glucose-treated human podocytes. Verouti SN; Tsilibary EC; Fragopoulou E; Iatrou C; Demopoulos CA; Charonis AS; Charonis SA; Drossopoulou GI Nephron Exp Nephrol; 2012; 122(1-2):36-50. PubMed ID: 23548800 [TBL] [Abstract][Full Text] [Related]
17. Effects of vitamin D analogs on the expression of plasminogen activator inhibitor-1 in human vascular cells. Wu-Wong JR; Nakane M; Ma J Thromb Res; 2006; 118(6):709-14. PubMed ID: 16371233 [TBL] [Abstract][Full Text] [Related]
19. Evidence for a regulatory role of inducible cAMP early repressor in protein kinase a-mediated enhancement of vitamin D receptor expression and modulation of hormone action. Huening M; Yehia G; Molina CA; Christakos S Mol Endocrinol; 2002 Sep; 16(9):2052-64. PubMed ID: 12198242 [TBL] [Abstract][Full Text] [Related]
20. Altered gene expression profile in the kidney of vitamin D receptor knockout mice. Li X; Zheng W; Li YC J Cell Biochem; 2003 Jul; 89(4):709-19. PubMed ID: 12858337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]